Innovative Medicines Canada (IMC) has said that the PMPRB’s Revised Draft Guidelines have too much ambiguity and could reduce the availability of new medicines in Canada.
Just over 60% of seniors living in long-term care were prescribed antidepressants in 2017, data analyzed by the institute indicates. That rose to 62% of residents by 2019 and 65% in 2021.